private:stemparsciences
|
3124297
|
Jun 3rd, 2019 12:00AM
|
StemPar Sciences
|
14
|
1.00
|
Open
|
Biotechnology
|
Jun 3rd, 2019 12:31PM
|
Jun 3rd, 2019 12:31PM
|
StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage.
Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer.
|
|
|
Open
|
|
|
|
|
|
|
StemPar Sciences
|
|
Health Care Equipment & Services
|
private:stemparsciences
|
3124297
|
Mar 23rd, 2018 12:00AM
|
StemPar Sciences
|
16
|
1.00
|
Open
|
Biotechnology
|
Mar 23rd, 2017 10:51AM
|
Mar 23rd, 2017 10:51AM
|
StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage.
Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer.
|
|
|
|
|
|
|
|
|
|
StemPar Sciences
|
|
Health Care Equipment & Services
|
private:stemparsciences
|
3124297
|
Feb 17th, 2018 12:00AM
|
StemPar Sciences
|
16
|
1.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage.
Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer.
|
|
|
|
|
|
|
|
|
|
StemPar Sciences
|
|
Health Care Equipment & Services
|
private:stemparsciences
|
3124297
|
Feb 16th, 2018 12:00AM
|
StemPar Sciences
|
16
|
1.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage.
Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer.
|
|
|
|
|
|
|
|
|
|
StemPar Sciences
|
|
Health Care Equipment & Services
|
private:stemparsciences
|
3124297
|
Feb 15th, 2018 12:00AM
|
StemPar Sciences
|
16
|
1.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage.
Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer.
|
|
|
|
|
|
|
|
|
|
StemPar Sciences
|
|
Health Care Equipment & Services
|
private:stemparsciences
|
3124297
|
Feb 14th, 2018 12:00AM
|
StemPar Sciences
|
16
|
1.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage.
Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer.
|
|
|
|
|
|
|
|
|
|
StemPar Sciences
|
|
Health Care Equipment & Services
|
private:stemparsciences
|
3124297
|
Feb 13th, 2018 12:00AM
|
StemPar Sciences
|
16
|
1.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage.
Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer.
|
|
|
|
|
|
|
|
|
|
StemPar Sciences
|
|
Health Care Equipment & Services
|
private:stemparsciences
|
3124297
|
Feb 12th, 2018 12:00AM
|
StemPar Sciences
|
16
|
1.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage.
Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer.
|
|
|
|
|
|
|
|
|
|
StemPar Sciences
|
|
Health Care Equipment & Services
|
private:stemparsciences
|
3124297
|
Feb 11th, 2018 12:00AM
|
StemPar Sciences
|
16
|
1.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage.
Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer.
|
|
|
|
|
|
|
|
|
|
StemPar Sciences
|
|
Health Care Equipment & Services
|
private:stemparsciences
|
3124297
|
Feb 10th, 2018 12:00AM
|
StemPar Sciences
|
16
|
1.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage.
Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer.
|
|
|
|
|
|
|
|
|
|
StemPar Sciences
|
|
Health Care Equipment & Services
|